🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Laboratorios Farmaceuticos ROVI (ROVI)

Madrid
Currency in EUR
78.050
-1.850(-2.32%)
Delayed Data
ROVI Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 3 days
Fair Value
Day's Range
77.40079.750
52 wk Range
46.78094.800
Bid/Ask
78.00 / 78.10
Prev. Close
79.9
Open
78.05
Day's Range
77.4-79.75
52 wk Range
46.78-94.8
Volume
26,623
Average Volume (3m)
78,617
1-Year Change
67.79%
Fair Value
Unlock
Fair Value Upside
Unlock
ROVI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
99.250
Upside
+27.162%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 4 consecutive years
Show more

Laboratorios Farmaceuticos ROVI Company Profile

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women’s health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Employees
2137
Market
Spain

Compare ROVI to Peers and Sector

Metrics to compare
ROVI
Peers
Sector
Relationship
P/E Ratio
27.6x17.9x−0.6x
PEG Ratio
−1.480.070.00
Price/Book
8.6x2.0x2.6x
Price / LTM Sales
5.3x2.1x3.2x
Upside (Analyst Target)
22.3%21.8%48.6%
Fair Value Upside
Unlock24.5%7.0%Unlock

FAQ

What Is the Laborat.Rovi (ROVI) Stock Price Today?

The Laborat.Rovi stock price today is 78.05

What Stock Exchange Does Laborat.Rovi Trade On?

Laborat.Rovi is listed and trades on the Madrid stock exchange.

What Is the Stock Symbol for Laborat.Rovi?

The stock symbol for Laborat.Rovi is "ROVI."

Does Laborat.Rovi Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 1.12%.

What Is the Laborat.Rovi Market Cap?

As of today, Laborat.Rovi market cap is 3.97B.

What is Laborat.Rovi Earnings Per Share?

The Laborat.Rovi EPS is 2.84.

What Is the Next Laborat.Rovi Earnings Date?

Laborat.Rovi will release its next earnings report on 06 Nov 2024.

From a Technical Analysis Perspective, Is ROVI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.